Skip to main content
Log in

Norepinephrine for hypotensive vasodilatation after cardiac surgery: impact on renal function

  • Original
  • Published:
Intensive Care Medicine Aims and scope Submit manuscript

Abstract

Objectives

Norepinephrine use in patients after cardiac surgery is controversial because of the fear that norepinephrine might decrease kidney function through regional vasoconstriction. Accordingly, we studied the renal effects of norepinephrine use for hypotensive vasodilatation after cardiac surgery.

Design and setting

Retrospective controlled study in the cardiothoracic ICU of tertiary hospital.

Patients

100 cardiac surgery patients with post-operative hypotensive vasodilatation and 100 control cardiac surgery patients.

Intervention

Treatment of hypotension (MAP<70 mmHg) with continuous norepinephrine infusion.

Measurements and results

We collected data on demographic and surgical characteristics, haemodynamics, serum creatinine and mortality. Just after surgery the norepinephrine group had a significantly higher mean central venous pressure, lower mean arterial pressure, and lower systemic vascular resistance index with a similarly elevated mean cardiac index. Despite norepinephrine administration at a mean peak dose of 7.3±6.4 µg/min the mean post-operative change in creatinine was not different between two groups on days 0, 2 or 4 after surgery.

Conclusions

Norepinephrine does not increase post-operative serum creatinine concentrations in patients with hypotensive vasodilatation after cardiac surgery. Concerns related to its potential adverse effects on the kidney function in this setting appear unjustified.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1. a

Similar content being viewed by others

Reference

  1. Argenziano M, Chen JM, Choudhri AF, Cullinane S, Garfein E, Weinberg AD, Smith CR, Rose EA, Landry DW, Oz MC (1998) Management of vasodilatory shock after cardiac surgery: identification of predisposing factors and use of a novel pressor agent. J Thorac Cardiovasc Surg 116:973–980

    CAS  PubMed  Google Scholar 

  2. Gomes WJ, Carvalho AC, Palma JH, Teles CA, Brance JNR, Silas MG, Buffolo E (1998) Vasoplegic syndrome after open heart surgery. J Cardiovasc Surg 39:619–623

    Google Scholar 

  3. Kristof AS, Magder S (1999) Low systemic vascular resistance state in patients undergoing cardiopulmonary bypass. Crit Care Med 27:1121–1127

    CAS  PubMed  Google Scholar 

  4. Mekontso-Dessap A, Houel R, Soustelle C, Kirsch M, Thebert D, Loisance DY (2001) Risk factors for post-cardiopulmonary bypass vasoplegia in patients with preserved left ventricular function. Ann Thorac Surg 71:1428–1432

    Article  CAS  PubMed  Google Scholar 

  5. Bellomo R, DiGiantomasso D (2001) Noradrenaline and the kidney; friends or foes. Crit Care 5:294–298

    Article  CAS  PubMed  Google Scholar 

  6. Sinsteden TD, O'Neil TJ, Hill S, Lifschitz MD, Stein JH (1989) The role of high-energy phosphate in norepinephrine-induced acute renal failure in the dog. Circulation Res 59:93–104

    Google Scholar 

  7. Schafferhans K, Heidbreder E, Grimm D, Heidland A (1986) Norepinephrine-induced acute renal failure: beneficial effects of atrial natriuretic factor. Nephron 44:240–244

    CAS  PubMed  Google Scholar 

  8. Chardigny C, Jebara VA, Acar C, Descombes JJ, Verbeuren TJ, Carpentier A, Fabiani JN (1993) Vasoreactivity of the radial artery: comparison with the internal mammary gastroepiploic arteries with implication for coronary artery surgery. Circulation 88:115–127

    Google Scholar 

  9. Chanda J, Canver CC (2001) Reversal of preexisting vasospasm in coronary artery conduits. Ann Thorac Surg 72:476–480

    Article  CAS  PubMed  Google Scholar 

  10. Chertow GM, Levy EM, Hammermeister KE, Grover F, Daley J (1998) Independent association between acute renal failure and mortality following cardiac surgery. Am J Med 104:343–348

    Google Scholar 

  11. Yeboah ED, Peter A, Pead JL (1972) Acute renal failure and open heart surgery. BMJ 1:415–418

    CAS  PubMed  Google Scholar 

  12. Conlon PJ, Stanfford-Smith M, White WD, Newman MF, King S, Winn MP, Landolfo K (1999) Acute renal failure following cardiac surgery. Nephrol Dial Transplant 14:1158–1162

    Google Scholar 

  13. Mangano CM, Diamondstone LS, Ramsay JG, Aggarwal A, Herskowitz A, Mangano DT (1998) Renal dysfunction after myocardial revascularization: risk factors, adverse outcomes, and hospital resource utilization. Ann Intern Med 128:194–203

    CAS  PubMed  Google Scholar 

  14. Parsonnet V, Dean D, Bernstein AD (1989) A method of uniform stratification of risk for evaluating the results of surgery in acquired adult heart disease. Circulation 79:I3–I12

    CAS  PubMed  Google Scholar 

  15. Nashef SA, Roques F, Michel P, Gauducheau E, Lemeshow S, Salamon R (1999) European system for cardiac operative risk evaluation (EuroSCORE). Eur J Cardiothorac Surg 16:9–13

    Article  CAS  PubMed  Google Scholar 

  16. Liu JJ, Doolan LA, Xie B, Chen JR, Buxton BF (1997) Direct vasodilator effect of milrinone, an inotropic drug, on arterial coronary bypass grafts. J Thorac Cardiovasc Surg 113:108–113

    CAS  PubMed  Google Scholar 

  17. Gitter R, Anderson JM, Jett GK (1996) Influence of milrinone and norepinephrine on blood flow in canine internal mammary artery grafts. Ann Thorac Surg 61:1367–1371

    Article  CAS  PubMed  Google Scholar 

  18. Lote CJ, Harper L, Savage COS (1996) Mechanisms of acute renal failure. Br J Anaesth 77:82–89

    CAS  PubMed  Google Scholar 

  19. Feneck RO, Sherry KM, Withigton PS, Oduro-Dominah A (2001) Comparison of the hemodynamic effects of milrinone with dobutamine in patients after cardiac surgery. J Cardiothorac Vasc Anesth 15:306–315

    Article  CAS  PubMed  Google Scholar 

  20. Feneck RO (1992) Intravenous milrinone following cardiac surgery. I. Effects of bolus infusion followed by variable dose maintenance infusion. The European Milrinone Multicentre Trial Group. J Cardiothorac Vasc Anesth 5:554–562

    Google Scholar 

  21. Feneck RO (1992) Intravenous milrinone following cardiac surgery. II. Influence of baseline hemodynamics and patients factors on therapeutic response. The European Milrinone Multicentre Trial Group. J Cardiothorac Vasc Anesth 5:563–567

    Google Scholar 

  22. Kikura M, Levy JH, Michelsen LG, Shanewise JS, Bailey JM, Sadel SM, Szlam F (1997) The effect of milrinone on hemodynamics and left ventricular function after emergence from cardiopulmonary bypass. Anesth Analg 85:16–22

    CAS  PubMed  Google Scholar 

  23. Gold J, Cullinane S, Chen J, Seo S, Oz MC, Oliver JA, Landry DW (2000) Vasopressin in the treatment of milrinone-induced hypotension in severe heart failure. Am J Cardiol 85:506–508

    Article  CAS  PubMed  Google Scholar 

  24. Gold JA, Cullinane S, Chen J, Oz MC, Oliver JA, Landry DW (2000) Vasopressin as an alternative to norepinephrine in the treatment of milrinone-induced hypotension. Crit Care Med 28:249–252

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Rinaldo Bellomo.

Additional information

This study was supported by the Austin and Repatriation Medical Centre Intensive Care Research Fund

Rights and permissions

Reprints and permissions

About this article

Cite this article

Morimatsu, H., Uchino, S., Chung, J. et al. Norepinephrine for hypotensive vasodilatation after cardiac surgery: impact on renal function. Intensive Care Med 29, 1106–1112 (2003). https://doi.org/10.1007/s00134-003-1810-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00134-003-1810-3

Keywords

Navigation